August 31, 2014 7:15 AM ET

Pharmaceuticals

Company Overview of Reliant Pharmaceuticals, Inc.

Company Overview

As of December 18, 2007, Reliant Pharmaceuticals, Inc. was acquired by GlaxoSmithKline plc. Reliant Pharmaceuticals, Inc., a pharmaceutical company, engages in the sale and marketing of cardiovascular pharmaceutical products. The company’s products include InnoPran XL and DynaCirc CR for the treatment of hypertension; and Omacor to reduce high triglycerides. It also offers Rythmol SR, which are extended release capsules; and Axid, a nizatidine. In addition, the company offers products for adjunct treatment of elevated cholesterol and triglycerides for the treatment of gastroesophageal reflux disease, and for secondary prevention of coronary events in patients with coronary heart disease. It ...

110 Allen Road

Liberty Corner, NJ 07938

United States

Founded in 1999

1,000 Employees

Phone:

908-580-1200

Fax:

908-542-9405

Key Executives for Reliant Pharmaceuticals, Inc.

Reliant Pharmaceuticals, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Akina, Inc. United States
Legacy Pharmaceuticals US, Inc. United States
US Pharma Lab, Incorporated United States
SCX Pharmaceuticals Inc. United States
Hanford Pharmaceuticals, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Reliant Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.